Log in
Enquire now
‌

US Patent 10023635 Antibodies to ICOS

Patent 10023635 was granted and assigned to Jounce Therapeutics, Inc. on July, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Jounce Therapeutics, Inc.
0
Current Assignee
‌
Jounce Therapeutics, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100236350
Patent Inventor Names
Stephen Sazinsky0
Jennifer S. Michaelson0
Kutlu Goksu Elpek0
Sriram Sathyanarayanan0
Date of Patent
July 17, 2018
0
Patent Application Number
150768670
Date Filed
March 22, 2016
0
Patent Citations Received
‌
US Patent 10968277 Gene signatures for determining ICOS expression
0
Patent Primary Examiner
‌
Ilia I Ouspenski
0
Patent abstract

Provided herein are various embodiments relating to antibodies. Some of the embodiments include agonist antibodies that bind ICOS. Such antibodies can be used in methods to treat, for example, cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10023635 Antibodies to ICOS

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.